Search

Your search keyword '"Receptors, Galanin antagonists & inhibitors"' showing total 33 results

Search Constraints

Start Over You searched for: Descriptor "Receptors, Galanin antagonists & inhibitors" Remove constraint Descriptor: "Receptors, Galanin antagonists & inhibitors"
33 results on '"Receptors, Galanin antagonists & inhibitors"'

Search Results

1. Alarin moderated myocardial hypertrophy via inhibiting cyclic adenosine monophosphate/protein kinase A signaling pathway to attenuate autophagy.

2. Treatment with celastrol protects against obesity through suppression of galanin-induced fat intake and activation of PGC-1α/GLUT4 axis-mediated glucose consumption.

3. Activation of galanin and cholecystokinin receptors in the lumbosacral spinal cord is required for ejaculation in male rats.

4. Effects of the Galanin Receptor Antagonist M40 on Cardiac Function and Remodeling in Rats with Heart Failure.

5. Modification of Anxious Behavior after Psychogenic Trauma and Treatment with Galanin Receptor Antagonist.

6. Effects of galanin subchronic treatment on memory and muscarinic receptors.

7. Galanin and galanin-like peptide modulate vasopressin and oxytocin release in vitro: the role of galanin receptors.

8. Effect of endogenous galanin on glucose transporter 4 expression in cardiac muscle of type 2 diabetic rats.

9. Antinociceptive effects of galanin in the nucleus accumbens of rats.

10. The cardiac sympathetic co-transmitter galanin reduces acetylcholine release and vagal bradycardia: implications for neural control of cardiac excitability.

11. Galanin regulation of LH release in male rats.

12. The combination of neurokinin-1 and galanin receptor antagonists ameliorates caerulein-induced acute pancreatitis in mice.

13. Galanin receptor antagonist m35 but not m40 or c7 ameliorates cerulein-induced acute pancreatitis in mice.

14. Galanin modulates vagally induced contractions in the mouse oesophagus.

15. Galanin, galanin receptors and drug targets.

16. Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective?

17. Galanin in the regulation of pancreatic vascular perfusion.

18. The role of the neuropeptide galanin in forming type-specific behavioral characteristics.

19. The role of galanin receptors in anticonvulsant effects of low-frequency stimulation in perforant path-kindled rats.

20. New galanin(1-15) analogues modified in positions 9, 10 and 11 act as galanin antagonists on glucose-induced insulin secretion.

21. Differential effect of galanin on proliferation of PC12 and B104 cells.

22. The brain galanin receptors: targets for novel antidepressant drugs.

23. Region specific galanin receptor/neuropeptide Y Y1 receptor interactions in the tel- and diencephalon of the rat. Relevance for food consumption.

24. [Role of neuropeptide galanin in formation of the typical behavioural characteristics].

25. Galanin as a modulator of anxiety and depression and a therapeutic target for affective disease.

26. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.

27. Synthesis and biological properties of new chimeric galanin analogue GAL(1-13)-[Ala10,11]ET-1(6-21)-NH2.

28. Galanin receptor ligands.

29. [The expression of galanin and galanin receptors in olfactory ensheathing cells and effects of galanin on cells proliferation].

30. Galanin-like peptide stimulates the release of gonadotropin-releasing hormone in vitro and may mediate the effects of leptin on the hypothalamo-pituitary-gonadal axis.

31. Enhanced hippocampal noradrenaline and serotonin release in galanin-overexpressing mice after repeated forced swimming test.

32. Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders.

33. The galanin antagonist M35 has intrinsic agonistic activity in the dorsal root ganglion.

Catalog

Books, media, physical & digital resources